Breaking News
Investing Pro 0
Free Webinar - Master Forex Trading Today! Don't Miss Out | Tuesday, June 6, 2023 | 01:00PM EDT Enroll Now
Close

Organicell Regenerative Medicine Inc (OCEL)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
0.010 -0.001    -7.41%
15:39:00 - Closed. Currency in USD ( Disclaimer )
Type:  Equity
Market:  United States
  • Volume: 250,757
  • Bid/Ask: 0.000 / 0.000
  • Day's Range: 0.010 - 0.011
Organicell Regenerative 0.010 -0.001 -7.41%

Organicell Regenerative Medicine Inc Company Profile

 
Get an in-depth profile of Organicell Regenerative Medicine Inc, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryPharmaceuticals
SectorHealthcare
Employees

22

Equity Type

ORD

Organicell Regenerative Medicine, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development of biological therapeutics for the treatment of degenerative diseases and to provide other related services. RAAM products are used in the healthcare industry administered through doctors and clinics. Its leading product, Zofin (Organicell Flow), is an acellular, biologic therapeutic derived from perinatal sources and is manufactured to retain naturally occurring microRNAs, without the addition or combination of any other substance or diluent. The product contains over 300 growth factors, cytokines, chemokines, and 102 unique microRNAs as well as other exosomes derived from perinatal tissues. It has obtained certain Investigation New Drug (IND), and emergency IND (eIND) approvals from the United States Food and Drug Administration (FDA), including applicable Institutional Review Board (IRB) approvals which authorized the Company to commence clinical trials.

Contact Information

Address 1951 Northwest 7th Avenue Suite 300
Miami, 33136
United States
Phone 888 963 7881
Fax -

Top Executives

Name Age Since Title
Bhupendra Kumar Modi 74 2022 Independent Chairman of the Board
Ian T. Bothwell 63 2016 Interim CEO, CFO & Director
Chuck Bretz 65 2022 Independent Vice Chairman of the Board
Marianne La Barbera - - Member of Medical Advisory Board
Mark Zhuk - - Member of Medical Advisory Board
Gerald S. Glauser 75 2022 Independent Director
Leathem S. Stearn 74 2022 Independent Director
Randolph Whipps - - Member of Medical Advisory Board
Robert Madda - - Member of Medical Advisory Board
Raymond Ishman - - Member of Medical Advisory Board
Billy Ray Ledbetter - - Member of Medical Advisory Board
Paul Francis Campion - - Member of Medical Advisory Board
Mohammed Siddiqui - - Member of Medical Advisory Board
Bryan Kelly - - Member of Medical Advisory Board
Fernando Pinto - - Member of Medical Advisory Board
Matthew Burnett - - Member of Medical Advisory Board
Eugene Rajaratnam - - Member of Medical Advisory Board
Damon M. Whitfield - - Member of Medical Advisory Board
Mitchell B. Sheinkop - - Member of Medical Advisory Board
Paul Thompson - - Member of Medical Advisory Board
Dennis J. Courtney - - Member of Medical Advisory Board
David C. Socol - - Member of Medical Advisory Board
Michale J. Barber - - Member of Medical Advisory Board
Harry Adelson - - Member of Medical Advisory Board
Rolf Wallin - - Member of Medical Advisory Board
Julian Gershon - - Member of Medical Advisory Board
Stephanie M. Singer - - Member of Medical Advisory Board
Barry Joseph Kuttner - - Member of Medical Advisory Board
Carolyn DeLucia - - Member of Medical Advisory Board
Mark L. Gonzalgo - - Member of Medical Advisory Board
Sonita Sadio - - Member of Medical Advisory Board
Bennett L. Willard - - Member of Medical Advisory Board
Alvaro J. Ocampo - - Member of Medical Advisory Board
William K. Kapp - - Member of Medical Advisory Board
Matthew Lief - - Member of Medical Advisory Board
Robert Neal Rouzier - - Member of Medical Advisory Board
Mounir Wassef - - Member of Medical Advisory Board
Adam Rosoff - - Member of Medical Advisory Board
Joseph Frank Pizzolato - - Member of Medical Advisory Board
Tami Meraglia - - Member of Medical Advisory Board
Juan Chavez - - Member of Medical Advisory Board
Henry C. Sobo - - Member of Medical Advisory Board
David M. Crane - - Member of Medical Advisory Board
Josh Sandell - - Member of Medical Advisory Board
Guryinder Pal Singh 61 2022 Independent Director
Glenn M. Charles - - Member of Medical Advisory Board
George C. Shapiro 61 2018 Chief Medical Officer & Director
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

OCEL Comments

Write your thoughts about Organicell Regenerative Medicine Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Rahul Ande
Rahul Ande Apr 28, 2021 11:25PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
this will be multi-day runner 🏃‍♂️
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email